Literature DB >> 11397025

Intraoperative endothelial damage is associated with increased risk of stenoses in infrainguinal vein grafts.

T G Nielsen1, B Hesse, M W Boehme, T V Schroeder.   

Abstract

OBJECTIVES: Saphenous vein injury is believed to predispose to vein graft stenoses. The aims of this study were to assess the endothelial injury associated with infrainguinal vein bypass surgery by serial measurements of serum thrombomodulin concentration as well as by platelet scintigraphy, and to relate these findings with the postoperative development of stenoses.
METHODS: In 35 patients undergoing vein bypass surgery serum thrombomodulin concentration was measured pre- and postoperatively. Autologous 111-indium labelled platelets were administered into the common femoral artery immediately after restoration of flow in the graft and scintigraphic images were obtained 4 and/or 24 h later.
RESULTS: Serum thrombomodulin increased markedly from median 17 ng/ml preoperatively to 32 ng/ml 1 day after surgery (p =0.00002). Platelet scintigraphy revealed a total of 62 focal activity accumulations, the majority being located in the anastomotic regions. Among the 30 patients with grafts remaining patent at 30 days stenoses occurred in nine (16%) of 55 regions with scintigraphic platelet accumulations as compared to only four (4%) of 94 regions without platelet accumulations (p =0.03).
CONCLUSIONS: The very high predictive value of a negative platelet scintigraphy (96%) strongly suggests that localised perioperative endothelial injury is an important pathogenetic factor in the development of vein graft stenoses. Copyright 2001 Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397025     DOI: 10.1053/ejvs.2001.1377

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  1 in total

1.  Improving arteriovenous fistula patency: Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation.

Authors:  Mark G MacAskill; David G Watson; Marie-Ann Ewart; Roger Wadsworth; Andrew Jackson; Emma Aitken; Graeme MacKenzie; David Kingsmore; Susan Currie; Paul Coats
Journal:  Vascul Pharmacol       Date:  2015-04-10       Impact factor: 5.773

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.